Works matching AU Bhat, Hans R.

Results: 9

Design and development of novel N‐(4‐aminobenzoyl)‐ l‐glutamic acid conjugated 1,3,5‐triazine derivatives as Pf‐DHFR inhibitor: An in‐silico and in‐vitro study.

Published in:

Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 4, p. 1, doi. 10.1002/jbt.23290

By:

Adhikari, Nayana;
Choudhury, Ayesha A. K.;
Shakya, Anshul;
Ghosh, Surajit K.;
Patgiri, Saurav J.;
Singh, Udaya P.;
Bhat, Hans R.

Publication type:

Article

Microwave‐assisted synthesis of hybrid PABA‐1,3,5‐triazine derivatives as an antimalarial agent.

Published in:

Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 9, p. 1, doi. 10.1002/jbt.22860

By:

Kashyap, Ankita;
Choudhury, Ayesha A. K.;
Saha, Ashmita;
Adhikari, Nayana;
Ghosh, Surajit K.;
Shakya, Anshul;
Patgiri, Saurav J.;
Bhattacharyya, Dibya R.;
Singh, Udaya P.;
Bhat, Hans R.

Publication type:

Article

In silico study, synthesis, and evaluation of the antimalarial activity of hybrid dimethoxy pyrazole 1,3,5‐triazine derivatives.

Published in:

Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 3, p. 1, doi. 10.1002/jbt.22682

By:

Gogoi, Pinku;
Shakya, Anshul;
Ghosh, Surajit K.;
Gogoi, Neelutpal;
Gahtori, Prashant;
Singh, Nardev;
Bhattacharyya, Dibya R.;
Singh, Udaya P.;
Bhat, Hans R.

Publication type:

Article

Discovery of novel 1,3,5‐triazine as adenosine A<sub>2A</sub> receptor antagonist for benefit in Parkinson's disease.

Published in:

Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 3, p. 1, doi. 10.1002/jbt.22659

By:

Masih, Anup;
Agnihotri, Amol K.;
Srivastava, Jitendra K.;
Pandey, Nidhi;
Bhat, Hans R.;
Singh, Udaya P.

Publication type:

Article

Discovery of novel pyrazole derivatives as a potent anti‐inflammatory agent in RAW264.7 cells via inhibition of NF‐ĸB for possible benefit against SARS‐CoV‐2.

Published in:

Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 3, p. 1, doi. 10.1002/jbt.22656

By:

Masih, Anup;
Agnihotri, Amol K.;
Srivastava, Jitendra K.;
Pandey, Nidhi;
Bhat, Hans R.;
Singh, Udaya P.

Publication type:

Article

Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100360

By:

Ali, Farak;
Alom, Shahnaz;
Shakya, Anshul;
Ghosh, Surajit K.;
Singh, Udaya P.;
Bhat, Hans R.

Publication type:

Article

1,3,5‐Triazine: A versatile pharmacophore with diverse biological activities.

Published in:

Archiv der Pharmazie, 2021, v. 354, n. 6, p. 1, doi. 10.1002/ardp.202000363

By:

Singh, Saumya;
Mandal, Milan K.;
Masih, Anup;
Saha, Ashmita;
Ghosh, Surajit K.;
Bhat, Hans R.;
Singh, Udaya P.

Publication type:

Article

Design, Synthesis, Antibacterial Activity, and Molecular Docking Studies of Novel Hybrid 1,3-Thiazine-1,3,5-Triazine Derivatives as Potential Bacterial Translation Inhibitor.

Published in:

Chemical Biology & Drug Design, 2012, v. 80, n. 4, p. 572, doi. 10.1111/j.1747-0285.2012.01430.x

By:

Singh, Udaya P.;
Pathak, Manish;
Dubey, Vaibhav;
Bhat, Hans R.;
Gahtori, Prashant;
Singh, Ramendra K.

Publication type:

Article

Design, Facile Synthesis, and Antibacterial Activity of Hybrid 1,3,4-thiadiazole-1,3,5-triazine Derivatives Tethered via -S- Bridge.

Published in:

Chemical Biology & Drug Design, 2012, v. 80, n. 4, p. 598, doi. 10.1111/j.1747-0285.2012.01433.x

By:

Dubey, Vaibhav;
Pathak, Manish;
Bhat, Hans R.;
Singh, Udaya P.

Publication type:

Article